Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 22
1946 60
1947 64
1948 54
1949 38
1950 44
1951 91
1952 169
1953 116
1954 106
1955 97
1956 118
1957 121
1958 128
1959 88
1960 85
1961 84
1962 66
1963 81
1964 92
1965 126
1966 142
1967 139
1968 173
1969 189
1970 182
1971 200
1972 219
1973 251
1974 277
1975 262
1976 327
1977 309
1978 307
1979 324
1980 268
1981 345
1982 397
1983 357
1984 399
1985 357
1986 405
1987 405
1988 394
1989 374
1990 415
1991 352
1992 364
1993 420
1994 347
1995 467
1996 418
1997 408
1998 451
1999 472
2000 480
2001 564
2002 666
2003 753
2004 772
2005 973
2006 1235
2007 1341
2008 1442
2009 1654
2010 1860
2011 1957
2012 2112
2013 2099
2014 1949
2015 2151
2016 2391
2017 2510
2018 2628
2019 2693
2020 2745
2021 2602
2022 2655
2023 2769
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

51,092 results

Results by year

Filters applied: . Clear all
Page 1
A Review and Assessment of Drug-Induced Thrombocytosis.
Vo QT, Thompson DF. Vo QT, et al. Ann Pharmacother. 2019 May;53(5):523-536. doi: 10.1177/1060028018819450. Epub 2018 Dec 10. Ann Pharmacother. 2019. PMID: 30525921 Review.
In all, 43 case reports of drug-induced thrombocytosis from a wide variety of drugs and drug classes were reviewed using a modified Naranjo probability scale that included criteria specific for thrombocytosis. CONCLUSIONS: Drug-induced thrombocy …
In all, 43 case reports of drug-induced thrombocytosis from a wide variety of drugs and drug classes were reviewed usin …
Statins Neuromuscular Adverse Effects.
Attardo S, Musumeci O, Velardo D, Toscano A. Attardo S, et al. Int J Mol Sci. 2022 Jul 28;23(15):8364. doi: 10.3390/ijms23158364. Int J Mol Sci. 2022. PMID: 35955495 Free PMC article. Review.
Statins are drugs widely prescribed in high-risk patients for cerebrovascular or cardiovascular diseases and are, usually, safe and well tolerated. However, these drugs sometimes may cause neuromuscular side effects that represent about two-third of all adverse …
Statins are drugs widely prescribed in high-risk patients for cerebrovascular or cardiovascular diseases and are, usually, safe and well tol …
Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies.
Sullivan RJ, Weber JS. Sullivan RJ, et al. Nat Rev Drug Discov. 2022 Jul;21(7):495-508. doi: 10.1038/s41573-021-00259-5. Epub 2021 Jul 27. Nat Rev Drug Discov. 2022. PMID: 34316029 Review.
The immune-related adverse events associated with treatment with immune checkpoint inhibitors result in significant morbidity for patients as well as considerable cost to the health-care system, and can limit the use of these beneficial drugs. Understanding t …
The immune-related adverse events associated with treatment with immune checkpoint inhibitors result in significant mor …
Immunotherapy Toxicities.
Sanchez K, Page DB, Urba W. Sanchez K, et al. Surg Oncol Clin N Am. 2019 Jul;28(3):387-401. doi: 10.1016/j.soc.2019.02.009. Epub 2019 Apr 5. Surg Oncol Clin N Am. 2019. PMID: 31079795 Review.
ICIs are associated with unique immune-mediated toxicities called immune-related adverse events. These toxicities may affect any organ system, and their precise mechanisms of action remain under investigation. ...This article summarizes toxicities, potential …
ICIs are associated with unique immune-mediated toxicities called immune-related adverse events. These toxicities may a …
Drug-induced hyperlactatemia.
Blohm E, Lai J, Neavyn M. Blohm E, et al. Clin Toxicol (Phila). 2017 Sep;55(8):869-878. doi: 10.1080/15563650.2017.1317348. Epub 2017 Apr 27. Clin Toxicol (Phila). 2017. PMID: 28447886 Review.
METHODS: We performed a literature search using PUBMED and Google Scholar for English language articles published after 1980 regarding medication induced hyperlactatemia and its management. Our search string resulted in 798 articles of which 138 articles met inclusion crit …
METHODS: We performed a literature search using PUBMED and Google Scholar for English language articles published after 1980 regarding medic …
Gastrointestinal and Hepatobiliary Immune-related Adverse Events: A Histopathologic Review.
Alruwaii ZI, Montgomery EA. Alruwaii ZI, et al. Adv Anat Pathol. 2022 Jul 1;29(4):183-193. doi: 10.1097/PAP.0000000000000346. Epub 2022 Apr 26. Adv Anat Pathol. 2022. PMID: 35470287 Review.
Despite their superior efficacy in treating certain ones, their global immune-activation effect leads to systemic side effects, referred to as immune-related adverse events. Immune-related adverse events affect a variety of …
Despite their superior efficacy in treating certain ones, their global immune-activation effect leads to systemic side effects …
Rheumatic immune-related adverse events induced by immune checkpoint inhibitors.
Zhong H, Zhou J, Xu D, Zeng X. Zhong H, et al. Asia Pac J Clin Oncol. 2021 Jun;17(3):178-185. doi: 10.1111/ajco.13346. Epub 2020 Jul 27. Asia Pac J Clin Oncol. 2021. PMID: 32717098 Free PMC article. Review.
Immune checkpoint inhibitors (ICIs) block the major inhibitory pathways in T cells, resulting in an augmented antitumor response. Immune-related adverse events (irAEs) are a new class of side effects caused by ICIs and tend to be more prevalent …
Immune checkpoint inhibitors (ICIs) block the major inhibitory pathways in T cells, resulting in an augmented antitumor response. Immune- …
Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance.
Wakabayashi T, Nakatsuji T, Kambara H, Niinomi I, Oyama S, Inada A, Ueno S, Uchida M, Iwanaga K, Iida T, Hosohata K. Wakabayashi T, et al. Curr Rev Clin Exp Pharmacol. 2022;17(2):144-148. doi: 10.2174/1574884716666210215104540. Curr Rev Clin Exp Pharmacol. 2022. PMID: 33588740 Free PMC article.
METHODS: We performed a retrospective pharmacovigilance disproportionality analysis using the Japanese Adverse Drug Event Report database. Adverse event reports submitted to the Pharmaceuticals and Medical Devices Agency were analyzed, and the reporting odds …
METHODS: We performed a retrospective pharmacovigilance disproportionality analysis using the Japanese Adverse Drug Event Repo …
Drug-induced lupus.
Rubin RL. Rubin RL. Expert Opin Drug Saf. 2015 Mar;14(3):361-78. doi: 10.1517/14740338.2015.995089. Epub 2015 Jan 2. Expert Opin Drug Saf. 2015. PMID: 25554102 Review.
INTRODUCTION: Drug-induced lupus (DIL) refers to an idiosyncratic side effect of numerous, apparently unrelated, medications, in which symptoms overlap with those of systemic lupus erythematosus. ...The role of complement and human leukocyte allotypes as well …
INTRODUCTION: Drug-induced lupus (DIL) refers to an idiosyncratic side effect of numerous, apparently unrelated, medica …
Drug-Induced Ototoxicity: Diagnosis and Monitoring.
Campbell KCM, Le Prell CG. Campbell KCM, et al. Drug Saf. 2018 May;41(5):451-464. doi: 10.1007/s40264-017-0629-8. Drug Saf. 2018. PMID: 29404977 Review.
Some of the guidelines and approaches are used to detect and monitor ototoxicity, while others are used to grade adverse events. Some of the audiologic measures are primary, while others are adjunct measures and may be tailored to the specific needs of the patient o …
Some of the guidelines and approaches are used to detect and monitor ototoxicity, while others are used to grade adverse events …
51,092 results
You have reached the last available page of results. Please see the User Guide for more information.